Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
Scientists warn of global crisis over failure to tackle tuberculosis

Heads of state, doctors and scientists will gather in New York next week to discuss one of the world’s most alarming medical crises: the failure of global efforts to tackle tuberculosis, the deadliest infectious disease on Earth.

Published
8 hours ago
From
The Guardian
TB symptom screen less likely to detect active TB in people taking HIV treatment

The four-symptom screen for active tuberculosis (TB) that is recommended for all people living with HIV in lower-income settings is less likely to detect active TB in

Published
14 September 2018
By
Keith Alcorn
Ending tuberculosis will take lower drug prices and a new, improved innovation ecosystem

Prisha and millions of other people with tuberculosis and drug-resistant tuberculosis do not need more patents for drugs they can’t afford. Instead, they need a better system with new incentives. They need real innovation. And right now they need a political declaration from the U.N.’s high-level meeting on tuberculosis that reaffirms countries’ legal right to use TRIPS flexibilities when they cannot otherwise afford the lifesaving treatments that Prisha and millions like her desperately need.

Published
13 September 2018
From
STAT
SimpliciTB Clinical Trial Launched with First Patients in Tbilisi, Georgia

New pivotal trial examines potential of BPaMZ regimen to shorten treatment for tuberculosis and multidrug-resistant tuberculosis.

Published
28 August 2018
From
TB Alliance
Dolutegravir-based ART effective and safe for HIV-positive people taking standard TB treatment

Dolutegravir-based antiretroviral therapy (ART) is effective and safe when taken at the same time as standard tuberculosis (TB) therapy, according to an international study presented at the

Published
24 August 2018
By
Michael Carter
How smartphones are becoming a weapon in the global fight against tuberculosis

Mobile technologies devised by researchers at the University of California, San Diego, and Johns Hopkins are allowing patients to use their phones to record daily medication intake. The encrypted videos are sent to public health workers who can watch them from their cubicles, instead of traveling long distances every day to visit patients at their homes or workplaces.

Published
21 August 2018
From
STAT
WHO announces landmark changes in MDR-TB treatment regimens

Major improvement in treatment outcomes and quality of life of patients with multidrug-resistant tuberculosis (MDR-TB) are expected, following key changes in MDR-TB treatment announced by WHO today.

Published
20 August 2018
From
World Health Organization
MSF applauds World Health Organization's recommendation of improved tuberculosis treatment options

Médecins Sans Frontières (MSF) today welcomed the new World Health Organization (WHO) recommendations for improved treatment for people with drug-resistant tuberculosis (DR-TB), prioritising the use of several oral drugs, including the newer drug bedaquiline, and minimising the use of drugs that must be injected.

Published
20 August 2018
From
ReliefWeb
South Africa strikes deal on new TB drug as WHO revisits guidance

The World Health Organization could soon start promoting a new tuberculosis drug that is now more affordable after South Africa brokered a deal with a pharmaceutical company to slash the price by half.

Published
13 August 2018
From
Devex
The 2018 Pipeline Report

Welcome to the 2018 Pipeline Report, Treatment Action Group’s annual review of therapeutics, diagnostics, vaccines, and preventive technologies in development for HIV, hepatitis C virus (HCV), and tuberculosis, along with immune-based and gene therapies and research toward a cure for HIV.

Published
24 July 2018
From
TAG
← First12345...110Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.